Scientific update

Screening of cancer targeting TCRs with the z-Movi®

With the quick development of new single-cell analysis technologies it is now possible to identify cancer-targeting T-Cell Receptors (TCRs) in a single experiment.

A recent review published in Methods in Enzymology, presented the z-Movi® Cell Avidity Analyzer among the future platforms for the screening of cancer-targeting TCRs.

“This technology is a lab-on-a-chip based method that allows the assessment, at the single cell resolution, of thousands of cell-cell and cell-ligand interactions in parallel. By ultrasound, the system allows contactless manipulation of biological objects of different sizes in a high-throughput and controlled manner.”

Thanks to Prof. Michael Platten at Universität Heidelberg and the other contributing authors for acknowledging our instrument! We are glad to see that cell avidity gets the attention it deserves.

For more information, read the full article on Methods in Enzymology, titled “High-throughput discovery of cancer-targeting TCRs”.

No items found.

No items found.

No items found.

Related scientific updates

Learn as much as you can by reading up on our scientific updates.

View all
Text Link
Enhancing efficacy against clear cell renal cell carcinoma through format-tuning of bispecific T cell engagers

Enhancing efficacy against clear cell renal cell carcinoma through format-tuning of bispecific T cell engagers

Scientific update
January 29, 2025
01-01-20

Text Link
Study using CTFM Published in Nature Communications

Study using CTFM Published in Nature Communications

Scientific update
June 15, 2016
01-01-20

Text Link
AFS 2.0 Paper Published in Methods

AFS 2.0 Paper Published in Methods

Scientific update
June 5, 2016
01-01-20

Text Link
Paper Using LUMICKS Technology Published in Nature

Paper Using LUMICKS Technology Published in Nature

Scientific update
July 21, 2016
01-01-20

No items found.